5 Likes
1 Like
UW QID tagged is about aromatase inhibitor mechanism, does not go into detail about SERMs. Think this change is overall correct. Support.
2 Likes
From ASCO: Raloxifene is not recommended for breast cancer risk reduction in premenopausal women . Raloxifene does not have demonstrated activity against established breast cancer and should not be used to treat breast cancer or prevent its recurrence.
1 Like